Related Experiment Video
Updated: Sep 9, 2026

A Simple and Efficient Method to Detect Nuclear Factor Activation in Human Neutrophils by Flow Cytometry
Published on: April 9, 2013
A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis
R Beyaert1, K Heyninck, S Van Huffel
1Unit of Molecular Signal Transduction in Inflammation, Department of Molecular Biology, Ghent University, Ghent, Belgium. rudi@dmb.rug.ac.be
Abstract:
Proper gene expression and cell growth are critical for the survival of all organisms. Nuclear factor-kappa B (NF-kappa B)-dependent gene expression and apoptosis play crucial roles in numerous cellular processes, and defects in their regulation may contribute to a variety of diseases including inflammation and cancer. Although there has recently been tremendous progress in our understanding of the signaling pathways that lead to NF-kappa B activation and apoptosis, signaling mechanisms that negatively regulate these processes are only partially understood. This review deals with the zinc finger protein A20, which has been characterized as a dual inhibitor of NF-kappa B activation and apoptosis. Its inducible expression by a wide variety of stimuli, including cytokines such as tumor necrosis factor, interleukin-1, and CD40, as well as bacterial and viral products such as lipopolysaccharide, Epstein-Barr virus latent membrane protein 1, and human T-cell leukemia virus type I Tax, suggests that it is involved in the negative feedback regulation of signaling. We will discuss the possible underlying mechanisms, placing emphasis on the role of several A20-binding proteins that have recently been described. Moreover, evidence is presented that A20 and A20-binding proteins are potential novel therapeutic tools in the treatment of a variety of diseases.
Insights
The zinc finger protein A20 inhibits nuclear factor-kappa B (NF-kappa B) activation and apoptosis, crucial for cell survival. A20 and its binding proteins show promise as novel therapeutic agents for diseases linked to NF-kappa B dysregulation.
Area of Science:
- Molecular Biology
- Cellular Signaling
- Immunology
Background:
- Nuclear factor-kappa B (NF-kappa B) and apoptosis are vital for cellular processes.
- Dysregulation of NF-kappa B and apoptosis is implicated in diseases like inflammation and cancer.
- Negative regulatory mechanisms for these pathways are not fully understood.
Purpose of the Study:
- To review the role of the zinc finger protein A20.
- To explore A20's function as a dual inhibitor of NF-kappa B activation and apoptosis.
- To discuss A20's potential as a therapeutic target.
Main Methods:
- Literature review focusing on A20 and its associated proteins.
- Analysis of signaling pathways involving NF-kappa B and apoptosis.
- Examination of A20's inducible expression patterns.
Main Results:
- A20 acts as a negative feedback regulator in cellular signaling.
- A20 expression is induced by various stimuli, including cytokines and microbial products.
- Several A20-binding proteins have been identified, contributing to its regulatory functions.
Conclusions:
- A20 is a key inhibitor of NF-kappa B signaling and apoptosis.
- A20-binding proteins are integral to A20's mechanism of action.
- A20 and its interacting proteins represent potential therapeutic strategies for related diseases.
Related Concept Videos
Co-activators and Co-repressors
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Co-activators and Co-repressors
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...

